发明名称 |
COMBINED USE OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID AND CYTARABINE (ARA-C) FOR THE TREATMENT OF LEUKEMIA |
摘要 |
Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C. |
申请公布号 |
EP3025712(A1) |
申请公布日期 |
2016.06.01 |
申请号 |
EP20150189348 |
申请日期 |
2007.08.02 |
申请人 |
SUNESIS PHARMACEUTICALS, INC. |
发明人 |
ADELMAN, DANIEL, C.;SILVERMAN, JEFFREY, A.;MICHELSON, GLENN;SCATENA, CAROLINE DARNE |
分类号 |
A61K31/4375;A61K31/513;A61P35/02 |
主分类号 |
A61K31/4375 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|